Gore completes acquisition of Conformal Medical

W. L. Gore & Associates, Inc. (Gore) a global materials science company, today announced it has completed the acquisition of Conformal Medical, developer of the investigational CLAAS AcuFORM System, a next-generation left atrial appendage occlusion (LAAO) technology. Gore announced its intent to acquire the company in January 2026.

“With this acquisition now complete, we are further strengthening Gore’s product development pipeline in endovascular treatment, with the goal of reaching more patients,” says Bret Snyder, board chair and CEO of W. L. Gore & Associates. “We are delighted to officially welcome Conformal Medical to our Enterprise.”

As a wholly owned subsidiary of Gore, Conformal Medical’s focus will remain on advancing its investigational technology and conducting clinical studies as planned.

“Joining the Gore Enterprise represents an important next chapter for Conformal Medical,” says James Reinstein, president and CEO of Conformal Medical. “Gore’s experience in medical technology development and its commitment to innovation will enable us to benefit from their science-driven approach and long-time commitment to improving patient care.”